ConA-glutamate interactions: New insights into its neuroprotective effect

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• L-glutamate is the primary excitatory neurotransmitter, and its excess causes excitotoxicity linked to neurodegenerative diseases like Alzheimer's and Parkinson's.
• Plant-derived compounds with antioxidant and anti-inflammatory properties are explored for neuroprotection.
• Canavalia ensiformis lectin (ConA) is utilized as a model lectin in central nervous system (CNS) research.

Purpose of the Study:

• To investigate the in vitro and in silico neuroprotective potential of ConA against glutamatergic excitotoxicity.
• To identify the specific protein domain and molecular mechanisms underlying ConA's neuroprotective action.

Main Methods:

• Cytotoxicity and neuroprotection assays were performed on PC12 cells using native and demetallized ConA.
• Molecular docking and fluorescence spectroscopy were employed to analyze ConA-glutamate interactions.
• Affinity and binding assays were conducted to determine the role of different ConA domains.

Main Results:

• ConA exhibited no cytotoxicity in PC12 cells within the tested concentration range (1-50 mM).
• ConA significantly enhanced PC12 cell viability (from 80% to over 90%) when exposed to glutamatergic excitotoxicity at 15.6 μg/mL.
• Binding assays revealed that the amino acid-binding site, not the carbohydrate recognition domain, is crucial for ConA's neuroprotective effect.

Conclusions:

• ConA demonstrates significant neuroprotective potential against L-glutamate-induced excitotoxicity in PC12 cells.
• The neuroprotection mechanism involves L-glutamate sequestration mediated by ConA's amino acid-binding site.
• These findings highlight ConA as a potential therapeutic agent for conditions involving glutamatergic excitotoxicity.